Request that the FDA implement urgent and decisive measures to protect animal and public health in light of mounting evidence regarding the risks associated with Zorbium (buprenorphine, NADA 141547, Schedule III opioid)

1 recorded connections shown. Select a record, office or person to follow its source references.

Start with

and connect to

Zoom to read. Drag to explore. Select a connection.

Dockets · As of Jun 30, 2026

Request that the FDA implement urgent and decisive measures to protect animal and public health in light of mounting evidence regarding the risks associated with Zorbium (buprenorphine, NADA 141547, Schedule III opioid): 1 outgoing connections shown. Point at anyone to see how they are linked.Showing bounded source connections. Dates come from the held records; missing relationships remain unknown.

The source record

As of Jun 30, 2026; may be out of date.

Docket type: Nonrulemaking
Title: Request that the FDA implement urgent and decisive measures to protect animal and public health in light of mounting evidence regarding the risks associated with Zorbium (buprenorphine, NADA 141547, Schedule III opioid)
Ingested at: 2026-06-30T05:20:00.498608+00:00

Every link on this map

The same connections as a table, with the reason each one is here.

Sort by

Connections of Request that the FDA implement urgent and decisive measures to protect animal and public health in light of mounting evidence regarding the risks associated with Zorbium (buprenorphine, NADA 141547, Schedule III opioid)

Dockets	What this connects to	Request that the FDA implement urgent and decisive measures to protect animal and public health in light of mounting evidence regarding the risks associated with Zorbium (buprenorphine, NADA 141547, Schedule III opioid) has a recorded connection to Dockets.	None